|
Jan 18
|
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
|
|
Jan 17
|
Bristol Myers Squibb (BMY) Stock Dips While Market Gains: Key Facts
|
|
Jan 17
|
Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
|
|
Jan 17
|
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
|
|
Jan 17
|
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
|
|
Jan 14
|
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
|
|
Jan 4
|
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
|
|
Jan 3
|
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
|
|
Jan 3
|
Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
|
|
Jan 3
|
Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025
|
|
Jan 2
|
Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years
|
|
Dec 31
|
Corcept Submits Application for Another Cushing's Syndrome Drug
|
|
Dec 31
|
Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?
|
|
Dec 31
|
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?
|
|
Dec 30
|
Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?
|
|
Dec 30
|
FDA approves BMS’ Opdivo Qvantig for solid tumour indications
|